Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Health Inks Agreement for Precision Medicine Tools With Falco Biosystems

NEW YORK — Molecular Health said on Tuesday that it has signed an agreement to use its MH BRCA and MH Mendel precision medicine software to help Japanese clinical testing firm Falco Biosystems evaluate disease-associated genes for its customers.

Part of Molecular Health's Guide sequencing data-analysis platform for personalized medicine, MH BRCA identifies and reports on inherited variants in BRCA1, BRCA2, and other genes linked to breast and ovarian cancer, while MH Mendel can analyze for a broader range of hereditary disease.

Under the terms of the deal, Falco will sequence patient-provided blood samples and identify genetic variants. Heidelberg, Germany-based Molecular Health will use MH BRCA and MH Mendel to analyze these variant data to distinguish between benign and pathogenic variants.

Molecular Health noted that it will use its MH Dataome platform for molecular and clinical datapoint mining, which integrates the Japanese reference genome ToMMo 3.5KJPNv2, to help with variant filtering and classification.

Additional terms of the deal were not disclosed.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.